Matarin Capital Management, LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 161 filers reported holding INTERSECT ENT INC in Q2 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
Matarin Capital Management, LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q2 2018$6,723,736,000
-31.7%
179,539
-28.4%
0.49%
-34.1%
Q1 2018$9,849,052,000
+65.8%
250,612
+36.7%
0.74%
+59.7%
Q4 2017$5,940,573,000
+764.7%
183,351
+731.3%
0.46%
+696.6%
Q3 2017$687,013,000
+17.4%
22,055
+5.3%
0.06%
+7.4%
Q2 2017$585,161,000
+63.0%
20,9360.0%0.05%
+54.3%
Q1 2017$359,052,000
+166.8%
20,936
+88.2%
0.04%
+133.3%
Q4 2016$134,600,00011,1240.02%
Other shareholders
INTERSECT ENT INC shareholders Q2 2018
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders